Cost Effectiveness of Apixaban Versus Aspirin for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation in Belgium
Conclusions
Apixaban is a cost-effective alternative to aspirin for patients with AF in Belgium who decline or cannot tolerate VKA treatment.
Source: Clinical Drug Investigation - Category: Drugs & Pharmacology Source Type: research
More News: Aspirin | Atrial Fibrillation | Belgium Health | Bleeding | Cardiology | Cardiovascular | Drugs & Pharmacology | Heart | Heart Attack | Hemorrhagic Stroke | Ischemic Stroke | Stroke | Study | Vitamins